BCR and neoplasm: Similarly, in multivariable analysis, neither race nor predominant tumor location was an independent predictor of BCR‐free survival, after adjusting for multiple clinicopathologic characteristics (HR = 1.18; 95% CI = 0.68‐2.02; P = .56 and HR = 1.13; 95% CI = 0.59‐2.15; P = .71, respectively) (Table 2).